Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-RISPERIDONE	0.25MG	TABLET	Resolved	2022-06-16	2022-09-08	162861
TEVA-RISPERIDONE	0.25MG	TABLET	Resolved	2020-06-04	2020-07-09	116672

Previous
1
…
16
17
18

Showing 171 to 172 of 172

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RISPERDAL	0.5MG	TABLET	Discontinued	2018-11-29	2019-04-02	68098
RISPERDAL	0.25MG	TABLET	Discontinued	2018-11-29	2019-04-02	68095
RISPERDAL	4MG	TABLET	Discontinued	2018-11-29	2019-04-02	68101
RISPERDAL	3MG	TABLET	Discontinued	2018-11-29	2019-04-02	68092
RISPERDAL	1MG	TABLET	Discontinued	2018-11-29	2019-04-02	68085
RISPERDAL	2MG	TABLET	Discontinued	2018-11-29	2019-04-02	68089
RISPERDAL ORAL SOLUTION	1MG	SOLUTION	To be discontinued	2023-04-27	2023-04-27	190894
SANDOZ RISPERIDONE	0.5MG	TABLET	Discontinued	2025-12-01	2025-12-02	272923
SANDOZ RISPERIDONE	3.0MG	TABLET	Discontinued	2021-03-22	2021-03-22	136095
SANDOZ RISPERIDONE	1MG	TABLET	Discontinued	2025-07-02	2025-07-03	261506

Showing 21 to 30 of 36